INHIBRX BIOSCIENCES, INC. (INBX) ROE
- 2026-06-30: ROE 260.83%.
- 2026-03-31: ROE 618.90%.
- 2025-12-31: ROE -1752.22%.
- 2025-09-30: ROE -421.09%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | 260.83% |
| 2026-03-31 | 618.90% |
| 2025-12-31 | -1752.22% |
| 2025-09-30 | -421.09% |
| 2025-06-30 | -238.76% |
| 2025-03-31 | 1824.35% |
| 2024-12-31 | 1263.30% |
| 2024-09-30 | 919.96% |
| 2024-06-30 | 744.83% |
| 2024-03-31 | -2344.01% |
| 2023-12-31 | -554.81% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -1752.22% |
| 2024-12-31 | 1263.30% |
| 2023-12-31 | -554.81% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |